未登录

N

Noriko Kobayashi

faculty of pharmacy

H指数:25

被引数:2,409

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of Dysphagia-Inducing Drugs and Risk of Aspiration Pneumonia: A Cross-Sectional Analysis Using a Japanese Claims Database

使用导致吞咽困难的药物与吸入性肺炎风险：一项基于日本理赔数据库的横断面分析

DRUGS-REAL WORLD OUTCOMES

IF0

2025-09-011

PRE

Sex Differences in Electrolyte Disturbances Among Diuretic Users According to Renal Function and Age

根据肾功能和年龄，利尿剂使用者中电解质紊乱的性别差异

IF3.8

2025-06-250

OA

Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer

整合的多组学分析和功能验证揭示TTK作为子宫内膜癌的新型EMT激活剂

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2023-02-257

OAAI

Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143

FRONTIERS IN ONCOLOGY

IF3.3

2022-05-2718

OAAI

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2021-06-2656

OAAI

MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1

IF5.2

2020-03-0552

OAAI

L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2019-12-0218

PREAI

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes

长链非编码RNA NEAT1通过涉及STAT3和肿瘤微环境相关基因的miR-361-regulated网络驱动侵袭性子宫内膜癌进展

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2019-07-08123

OAAI

Expression of precipitating factors of pruritus found in humans in an imiquimod-induced psoriasis mouse model

IF3.6

2019-06-0112

OAAI

Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experience

INVESTIGATIONAL NEW DRUGS

IF2.7

2017-02-011

PREAI

Distribution of Lymph Node Metastasis Sites in Endometrial Cancer Undergoing Systematic Pelvic and Para-Aortic Lymphadenectomy: A Proposal of Optimal Lymphadenectomy for Future Clinical Trials

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2014-04-0543

PRE

PREDICTIVE MARKERS OF CLINICAL OUTCOME FOR BREAST CANCER PATIENTS TREATED IN PHASE 1 TRIALS: NATIONAL CANCER CENTER HOSPITAL EXPERIENCE

IF7.9

2013-11-010

OAAI

PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation

JOURNAL OF OVARIAN RESEARCH

IF4.2

2013-01-2623

OAAI

Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy

JOURNAL OF GYNECOLOGIC ONCOLOGY

IF3.7

2013-01-0132

OAAI

Tumor Response After Small Dose of Chemoradiation Therapy in Patients With Esophageal Carcinoma

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2012-11-010

OAAI

Multivariate survival analysis of the patients with recurrent endometrial cancer

子宫内膜癌复发患者多因素生存分析

JOURNAL OF GYNECOLOGIC ONCOLOGY

IF3.7

2011-01-0150

OAAI

Growth Differentiation Factor-9 Mediates Follicle-Stimulating Hormone-Thyroid Hormone Interaction in the Regulation of Rat Preantral Follicular Development

IF3.3

2009-10-1551

OAAI

Thioredoxin reduces C-C chemokine-induced chemotaxis of human eosinophils

硫氧还蛋白降低c-c趋化因子诱导的人嗜酸性粒细胞趋化性

IF12

2009-07-0817

PREAI

Estrogen receptor α polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen

IF3.6

2002-03-0181

PREAI

Increased apoptosis of human fetal membranes in rupture of the membranes and chorioamnionitis

IF2.5

2002-02-0131

PREAI